The genetics of Parkinson disease
- PMID: 20938043
- PMCID: PMC3044594
- DOI: 10.1177/0891988710383572
The genetics of Parkinson disease
Abstract
Parkinson disease (PD) is the second most common neurodegenerative disorder. In most instances, PD is thought to result from a complex interaction between multiple genetic and environmental factors, though rare monogenic forms of the disease do exist. Mutations in 6 genes (SNCA, LRRK2, PRKN, DJ1, PINK1, and ATP13A2) have conclusively been shown to cause familial parkinsonism. In addition, common variation in 3 genes (MAPT, LRRK2, and SNCA) and loss-of-function mutations in GBA have been well-validated as susceptibility factors for PD. The function of these genes and their contribution to PD pathogenesis remain to be fully elucidated. The prevalence, incidence, clinical manifestations, and genetic components of PD are discussed in this review.
Conflict of interest statement
Figures



Similar articles
-
Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?Mov Disord. 2009 Apr 30;24(6):833-8. doi: 10.1002/mds.22214. Mov Disord. 2009. PMID: 19224617
-
Clinical genetics of Parkinson's disease and related disorders.Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5. Parkinsonism Relat Disord. 2007. PMID: 18267241 Review.
-
Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.BMC Neurol. 2008 Jan 22;8:1. doi: 10.1186/1471-2377-8-1. BMC Neurol. 2008. PMID: 18211709 Free PMC article.
-
Structural genomic variations and Parkinson's disease.Minerva Med. 2017 Oct;108(5):438-447. doi: 10.23736/S0026-4806.17.05246-6. Epub 2017 May 25. Minerva Med. 2017. PMID: 28541025 Review.
-
Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24. Parkinsonism Relat Disord. 2012. PMID: 22445250
Cited by
-
Knowledge of and interest in genetic results among Parkinson disease patients and caregivers.J Genet Couns. 2014 Feb;23(1):114-20. doi: 10.1007/s10897-013-9618-y. Epub 2013 Jun 9. J Genet Couns. 2014. PMID: 23748874 Free PMC article.
-
Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification.Biomed Res Int. 2021 Nov 13;2021:8171236. doi: 10.1155/2021/8171236. eCollection 2021. Biomed Res Int. 2021. PMID: 34812409 Free PMC article.
-
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
-
Parkinson's Neuropathology Puzzle: A Systematic Review Uncovering the Pathological Culprits Behind the Neurological Disease.Cureus. 2023 Aug 29;15(8):e44353. doi: 10.7759/cureus.44353. eCollection 2023 Aug. Cureus. 2023. PMID: 37664277 Free PMC article. Review.
-
N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders.CNS Neurol Disord Drug Targets. 2018;17(3):216-232. doi: 10.2174/1871527317666180412153612. CNS Neurol Disord Drug Targets. 2018. PMID: 29651972 Free PMC article. Review.
References
-
- de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 suppl 5):S21–S23. - PubMed
-
- Sellbach AN, Boyle RS, Silburn PA, Mellick GD. Parkinson's disease and family history. Parkinsonism Relat Disord. 2006;12(7):399–409. - PubMed
-
- Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet. 2006;7(4):306–318. - PubMed
-
- Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991;114(pt 5):2283–2301. - PubMed
-
- Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet. 2004;363(9423):1783–1793. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous